Alexis B. Cortot

11.3k citations

185 papers · 3.8k indexed · 2 hit papers · h-index 28

Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 121
- Lung Cancer Diagnosis and Treatment 43
Oncology top 1%
- Lung Cancer Research Studies 44
- Colorectal Cancer Treatments and Studies 30
- Cancer Immunotherapy and Biomarkers 20
Cancer Research top 5%
- Cancer Genomics and Diagnostics 16
Hepatology top 5%
- Liver physiology and pathology 12
Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 13

Co-authors: Pasi A. Jänne Dalia Ercan Marzia Capelletti Nathanael S. Gray Kwok‐Kin Wong Marie Wislez Julien Mazières Cai‐Hong Yun
Cited by: Pulmonary and Respiratory Medicine Oncology Cancer Research
Journals: Nature (1 paper)Journal of Clinical Oncology (21 papers)JNCI Journal of the National Cancer Institute (1 paper)
Partner nations: France United States Germany

In The Last Decade

Alexis B. Cortot

167 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Alexis B. Cortot

Since Specialization

Citations

This map shows the geographic impact of Alexis B. Cortot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexis B. Cortot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexis B. Cortot more than expected).

Fields of papers citing papers by Alexis B. Cortot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexis B. Cortot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexis B. Cortot. The network helps show where Alexis B. Cortot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alexis B. Cortot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alexis B. Cortot Line = papers co-authored together Alexis B. Cortot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study Lung Cancer ·T. Pierret,Laurent Greillier,Florian Guisier,Catherine Daniel,R. Descourt,Loïck Galland,Olivier Molinier,C. Decroisette,Alexis B. Cortot,Diane Moreau,Laurence Gamé,Marie Wislez,Nicolas Cloarec,Hubert Curcio,Nicolas Delberghe,J. Cadranel,Boris Duchemann,Anne Claire Toffart,C. Chouaïd,J.B. Auliac	2025	0
2	Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer Therapeutic Advances in Medical Oncology ·A. Roboubi,Eric Wasielewski,Soraya Bordier,A. Turlotte,Geoffrey Pavaut,Arnaud Scherpereel,Alexis B. Cortot,Clément Gauvain	2025	1
3	Association épidémiologique entre pollution et altérations oncogéniques dans le cancer du poumon Revue des Maladies Respiratoires Actualités ·Serge Leblanc,Michaël Génin,Florent Occelli,L. Dauchet,V. Leblanc,S. Hominal,Acya Bizieux‐Thaminy,S. Thomassin,Marie Bernardi,E. Briens,L. Belmont,C. Lefoll,David Renault,M. Paysse,A. Tierce,Eric Wasielewski,Aghilès Hamroun,D. Debieuvre,Alexis B. Cortot	2024	0
4	1359P Relationship between tumor TP53 gene mutation, circulating anti-p53 antibodies and response to first-line osimertinib in EGFR-mutated NSCLC patients Annals of Oncology ·Marc G. Denis,G. Herbreteau,Christine Sagan,S. Charpentier,Audrey Vallée,Jacques Cadranel,Clarisse Audigier-Valette,Pascale Tomasini,Philippe Masson,E. Pons-Tostivint,H. Curcio,Nicolas Girard,Alexis B. Cortot,O. Molinier,I. Monnet,M. Marcq,T. Urban,D. Moro-Sibilot,H. Léna,Jaafar Bennouna	2023	1
5	585P Real-world outcomes in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations receiving mobocertinib Annals of Oncology ·Tony Mok,Geoffrey Liu,S.F. Nyaw,H. Curcio,Alexis B. Cortot,T.Y. Kam,R. Descourt,Y.K.J. Chik,Parneet Cheema,J.M. Gwinnutt,Eric N. Churchill,J. Nyborn,E. Curran,Y. Yin,Kelly K. Chong,Y. Tanaka-Chambers,Julia Kretz,Jacques Cadranel	2023	1
6	Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study Cancers ·R. Descourt,M. Pérol,G. Rousseau-Bussac,David Planchard,B. Mennecier,Marie Wislez,Jacques Cadranel,Alexis B. Cortot,Florian Guisier,Loïck Galland,Pascal Dô,Roland Schött,Éric Dansin,Jennifer Arrondeau,J.B. Auliac,Margaux Geier,C. Chouaïd	2022	5
7	Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study Cancers ·Jean‐Baptiste Assié,F. Crépin,Emmanuel Grolleau,Anthony Canellas,Margaux Geier,Aude Grébert-Manuardi,Nabila Akkache,Aldo Renault,Pierre-Alexandre Hauss,Marielle Sabatini,V. Bonnefoy,Alexis B. Cortot,Marie Wislez,Clément Gauvain,C. Chouaïd,Arnaud Scherpereel,I. Monnet	2022	11
8	Dual-Energy CT Perfusion of Invasive Tumor Front in Non–Small Cell Lung Cancers Radiology ·Julie Dewaguet,Marie‐Christine Copin,Alain Duhamel,J Faivre,Valérie Deken,Martin Sedlmair,Thomas Flohr,Bernhard Schmidt,Alexis B. Cortot,Eric Wasielewski,Jacques Rémy,Martine Rémy‐Jardin	2021	16
9	Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database OncoImmunology ·Quentin Scanvion,Johana Béné,Sophie Gautier,Aurélie Grandvuillemin,Christine Le Beller,Chouki Chenaf,Nicolas Etienne,Solenn Brousseau,Alexis B. Cortot,Laurent Mortier,D. Staumont‐Sallé,Franck Morschhauser,Alexandra Forestier,Matthieu Groh,David Launay,É. Hachulla,Myriam Labalette,Jean‐Emmanuel Kahn,Guillaume Lefèvre	2020	37
10	Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma Lung Cancer ·Simon Baldacci,V. Grégoire,Enrico Patrucco,Roberto Chiarle,Philippe Jamme,Eric Wasielewski,C. Descarpentries,Marie‐Christine Copin,Mark M. Awad,Alexis B. Cortot	2020	11
11	Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial Clinical Lung Cancer ·Jaafar Bennouna,Nicolas Girard,Clarisse Audigier-Valette,Aurélie Le Thuaut,Radj Gervais,Philippe Masson,M. Marcq,Olivier Molinier,Alexis B. Cortot,D. Debieuvre,J. Cadranel,H. Léna,Denis Moro‐Sibilot,C. Chouaïd,B. Mennecier,T. Urban,Christine Sagan,Ludivine Perrier,Fabrice Barlési,Marc G. Denis	2019	19
12	Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC Cancer Medicine ·Paul Lesueur,Alexandre Escande,Juliette Thariat,E. Vauléon,I. Monnet,Alexis B. Cortot,D. Lerouge,S. Danhier,Pascal Dô,Catherine Dubos‐Arvis,C. Chouaïd,Radj Gervais	2018	36
13	Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer European Radiology ·Grégory Kuchcinski,Émilie Le Rhun,Alexis B. Cortot,Élodie Drumez,Romain Duhal,Maxime Lalisse,Julien Dumont,Renaud Lopes,Jean‐Pierre Pruvo,X. Leclerc,Christine Delmaire	2017	12
14	Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort Annals of Oncology ·Julien Mazières,Fabrice Barlési,Thomas Filleron,Benjamin Besse,I. Monnet,Michèle Beau‐Faller,Solange Peters,Éric Dansin,Martin Früh,Miklos Pless,Rafael Rosell,Marie Wislez,P. Fournel,Virginie Westeel,Federico Cappuzzo,Alexis B. Cortot,Denis Moro‐Sibilot,Julie Milia,Oliver Gautschi	2015	219
15	La maladie de Castleman : observations inhabituelles et revue de la littérature Revue de Pneumologie Clinique ·A. Baranzelli,Rias Akkad,B. Bouchindhomme,Nunzia Tacelli,J. Delourme,X. Dhalluin,J.J. Lafitte,Arnaud Scherpereel,Martine Rémy-Jardin,Alexis B. Cortot	2013	1
16	Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway Cancer Research ·Alexis B. Cortot,Claire E. Repellin,Takeshi Shimamura,Marzia Capelletti,Kreshnik Zejnullahu,Dalia Ercan,James G. Christensen,Kwok‐Kin Wong,Nathanael S. Gray,Pasi A. Jänne	2012	163
17	Patterns of EGFR, HER2, TP53 , and KRAS Mutations of p14arf Expression in Non–Small Cell Lung Cancers in Relation to Smoking History Cancer Research ·Mounia Mounawar,Anush Mukeria,Florence Le Calvez‐Kelm,Rayjean J. Hung,Hélène Renard,Alexis B. Cortot,Claire Bollart,Давид Заридзе,Paul Brennan,Paolo Boffetta,Élisabeth Brambilla,Pierre Hainaut	2007	83
18	Lymphome pulmonaire du MALT révélant un sida Revue des Maladies Respiratoires ·Alexis B. Cortot,Vincent Cottin,B. Issartel,David Meyronet,Bertrand Coiffier,J.-F. Cordier	2006	5
19	[An enigmatic occlusive syndrome]. PubMed ·D Lescut,Colombel Jf,M. Parent,P Bonnière,Fabien Guillemot,Alexis B. Cortot,Paris Jc	1988	1
20	[Palliative treatment of cancer of the esophagus and cardia by laser photo-ablation]. PubMed ·Maunoury,Brunetaud Jm,D. Cochelard,O Delette,Alexis B. Cortot,Paris Jc	1987	5

About Alexis B. Cortot

Alexis B. Cortot is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Hepatology, having authored 185 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (121 papers), Lung Cancer Research Studies (44 papers), Lung Cancer Diagnosis and Treatment (43 papers), Colorectal Cancer Treatments and Studies (30 papers), Cancer Immunotherapy and Biomarkers (20 papers), Cancer Genomics and Diagnostics (16 papers), PI3K/AKT/mTOR signaling in cancer (13 papers) and Liver physiology and pathology (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.7k citations), Oncology (2.2k citations) and Cancer Research (609 citations). Alexis B. Cortot has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Pasi A. Jänne, Dalia Ercan, Marzia Capelletti, Nathanael S. Gray, Kwok‐Kin Wong, Marie Wislez, Julien Mazières, Cai‐Hong Yun, Michael J. Eck and John R. Engen. Their work appears in journals such as Nature, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact